Radium chloride radium chloride is weakly paramagnetic with a magnetic susceptibility of 1.05. It also differs from barium chloride by the flame color, which is red as opposed to green for barium chloride. Radium chloride is still used for the initial stages of the separation of radium from barium during the extraction of radium from pitchblende. The large quantities of material involved (tonnes of ore for milligrams of radium) favour this less costly (but less efficient) method over those based on radium bromide or radium chromate (used for the later stages of the separation). It was also used in medicine to produce
Radium-223 kBq/ml), sodium chloride, and other ingredients for intravenous injection. Algeta ASA was later acquired by Bayer who is now the sole owner of Xofigo. The recommended regimen is six treatments of 55 kBq/kg (1.3 uCi per kg), repeated at 4-week intervals. The use of radium-223 to treat metastatic bone cancer relies on the ability of alpha radiation from radium-223 and its short-lived decay products to kill cancer cells. Radium is preferentially absorbed by bone by virtue of its chemical similarity to calcium, with most radium-223 that is not taken up by the bone being cleared, primarily via the gut, and